ArticleEuPA open proteomics2017

Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease.

Scott D Bringans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.